Developing new treatments for asthma
The Next Wave of Asthma Therapeutics
This study is exploring new ways to treat asthma by using advanced technology to find better options for people who struggle with current treatments, focusing on reducing inflammation in the lungs.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Biotherapeutics, INC. NIH-funded |
| Lab location | 1 site (Blacksburg, United States) |
| Project ID | NIH-11063906 on NIH RePORTER |
What this research studies
This research focuses on creating innovative therapies for asthma by utilizing advanced computational modeling and experimental techniques. The project aims to target a new immunoregulatory pathway that could improve treatment outcomes for patients suffering from various forms of asthma, particularly those who do not respond well to existing therapies. By addressing the underlying inflammation associated with asthma, the research seeks to provide safer and more effective options for patients. The approach involves manipulating regulatory T cells to enhance their ability to suppress inflammation.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with asthma, particularly those who have not responded adequately to existing therapies.
Not a fit: Patients with mild asthma who are well-controlled on current therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer asthma treatments for patients who currently have limited options.
How similar studies have performed: While there have been challenges in previous attempts to develop new asthma therapies, the innovative approach of targeting regulatory T cells represents a novel direction that has not been extensively tested.
Where this research is happening
Blacksburg, United States
- Biotherapeutics, INC. — Blacksburg, United States (Active)
Researchers
- Principal investigator: Bassaganya-Riera, Josep — Biotherapeutics, INC.
- Study coordinator: Bassaganya-Riera, Josep
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.